FREEHOLD, NJ--(MARKET WIRE)--Jul 19, 2006 -- New Life Scientific, Inc. (OTC BB:NWLS.OB - News) announced that US-based Biotech Company awarded contract to Pharma Trials International (PTI), subsidiary of NWLS. It is a study of a novel cardiovascular agent that will be conducted by PTI in Europe. The project is scheduled for completion in the third quarter of 2008. This is PTI’s second project with NWLS involvement, and both projects will be managed from PTI’s headquarters in Hillsborough, NJ.
